Oxford Immunotec
Oxford Immunotec Nabs CE Mark for COVID-19 T-Cell Response Test
The firm said its T-cell test complements serology testing and provides a more comprehensive view of the adaptive immune response to SARS-CoV-2 infection.
Oxford Immunotec, Valneva Collaborate on COVID-19 Vaccine Study
Oxford Immunotec's T-Spot Discovery SARC-CoV-2 test will be used to assess whether Valneva's vaccine candidate induces a T-cell response.
PerkinElmer to Buy Oxford Immunotec for $591M
The deal will enable PerkinElmer to grow its infectious disease testing portfolio to include latent tuberculosis detection, it said.
Sep 25, 2018
Quest Acquires US Lab Business of Oxford Immunotec
May 1, 2018
Oxford Immunotec Q1 Revenues Relatively Flat
Apr 26, 2018
Oct 31, 2017
Oxford Immunotec Q3 Revenues Rise 17 Percent
Aug 1, 2017